Article
Genetic variants in lncRNA SRA and risk of breast cancer.
Oncotarget - 19 Apr 2016
Yan Rui, Wang Kaijuan, Peng Rui, Wang Shuaibing, Cao Jingjing, Wang Peng, Song Chunhua
Abstract excerpt
Long non-coding RNA (lncRNA) steroid receptor RNA activator (SRA) has been identified to activate steroid receptor transcriptional activity and participate in tumor pathogenesis. This case-control study evaluated the association between two haplotype tagging SNPs (htSNPs) (rs10463297, rs801460) of the whole SRA sequence and breast cancer risk. We found that rs10463297 TC genotype significantly increased BC risk...
Read the complete abstract on PubMed